NCT03009786

Brief Summary

The main objective of this study is to achieve cross-cultural and psychometric validation of the Xerostomia Inventory initially developed in English language into French Language. This will be achieved in two stages: First, cross-cultural validation, and a second, psychometric validation The cross-cultural validation will be performed according to the methodology of the Institute for Work and Health, according to the recommended six phases. In a second step, the psychometric validation will be done using longitudinal study. Indeed, an observational, longitudinal, and prospective study will be set up. Analysis of the results will help define the feasibility and acceptability of the tool, its validity (content validity, perceived validity, construct validity, concurrent validity, and discriminant validity), its reliability (internal consistency and reproducibility over time). Longitudinal follow-up of patients is expected to also assess the predictive validity and responsiveness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 27, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 4, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

May 5, 2017

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 27, 2020

Completed
3.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2024

Completed
Last Updated

February 21, 2024

Status Verified

February 1, 2024

Enrollment Period

3.5 years

First QC Date

December 27, 2016

Last Update Submit

February 20, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • The psychometric properties of the Xerostomia Inventory measured by questionnaire

    The Xerostomia Inventory to be validated is an 11-item summated rating scale which combines the responses to 11 individual items into a single continuous scale score which represents the severity of chronic xerostomia; higher scores represent more severe symptoms. Respondents are asked to choose one of five responses: Never: 1 point; Hardly ever: 2 points; Occasionally: 3 points; Fairly often: 4 points; Very often: 5 points; to the following statements referring to the previous 4 weeks.

    month 6

Study Arms (1)

Elderly institutionalized subjects or outpatients

Other: Measurement of salivary flow

Interventions

A compress of about 0.95 g which is weighed and then placed under the tongue of the subject for 5 minutes. Once the time has elapsed, the compress is weighed, a simple subtraction determines the weight of saliva produced in 5 minutes

Elderly institutionalized subjects or outpatients

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Elderly institutionalized subjects or outpatients aged 65 years or over

You may qualify if:

  • Age: 65 years or more
  • Outpatients or nursing home residents
  • Speaking French fluently
  • Willing to participate to the study

You may not qualify if:

  • Incapability to understand the instructions or to fill alone the questionnaire
  • Under guardianship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Reims

Reims, 51092, France

Location

MeSH Terms

Conditions

Xerostomia

Condition Hierarchy (Ancestors)

Salivary Gland DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 27, 2016

First Posted

January 4, 2017

Study Start

May 5, 2017

Primary Completion

October 27, 2020

Study Completion

February 20, 2024

Last Updated

February 21, 2024

Record last verified: 2024-02

Locations